AI listens to your voice to spot diabetes stress

NCT ID NCT06985862

Terminated Knowledge-focused Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether artificial intelligence can detect stress in people with type 1 diabetes by analyzing their voice recordings. Participants record their voice four times a day for a period. The goal is to develop a tool that helps patients and doctors better understand and manage stress, which can affect blood sugar levels. The study is currently suspended and involves 35 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Voice recording and AI analysis
What this could lead to: If successful, this could lead to a tool that helps people with type 1 diabetes better manage stress and improve blood sugar control.
What could go wrong: This is a small, early-stage study that is currently suspended. The AI tool may not accurately detect stress or lead to practical benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 1

Contacts and locations

Locations

Angers University Hospital

Angers, Site Principal Investigator, 49100, France
CERITD (Centre d'Etudes et de Recherches pour l'Intensification du Traitement du Diabète)

Évry, 91058, France
Grenoble University Hospital

Grenoble, 38043, France
Rennes University Hospital

Rennes, France, 35200, France
Strasbourg University Hospital

Strasbourg, France, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.